CLGN

NASDAQ · Biotechnology

Collplant Biotechnologies Lt

Penny Stocks Biotech Stocks Healthcare Stocks

$0.42

+0.00 (+0.36%)

As of May 16, 2:31 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +3,981.2% upside

Low Target $14.35

Average Target $17.19

High Target $29.92

Current Price $0.42

Current
$0.42

Target
$17.19

$14.35 $17.19 avg $29.92

Scenario Analysis

Bear Case

$14.35

3,306.9%

Low target

Base Case

$17.19

+3,981.2%

Avg target

Bull Case

$29.92

+7,003.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.98

-91.5% from high

52-Week Low

$0.27

+55.4% from low

Target vs 52W High

$17.19

+245.2% vs high

Next Earnings Report

May 21, 2026

until earnings

EPS Est: $-0.19

Earnings in 4 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%